Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ALNT Allient Inc posts 209 percent Q4 2025 EPS beat lifting shares 57 percent on strong investor sentiment LiveRamp Holdings RAMP Cash Flow Analysis LiveRamp Holdings Inc posts 86 EPS beat on strong client demand VSEC VSE Corporation beats Q4 2025 EPS estimates by 274 percent shares rise 455 percent in daily trading Is First Mid FMBH stock cyclical First Mid posts 23 EPS miss vs analyst estimates Market Wrap Tech outperforms while consumer stocks lag in flat trading Is Am Supercon AMSC stock hitting resistance today Q1 2026 Better Than Expected CFG Citizens Fin Q1 2026 earnings top estimates 56 percent revenue growth fails to lift shares Tasmanian Government Apology Sparks Potential Financial Liabilities in Stolen Remains Scandal Whitbreads Strategic Reset Faces Scrutiny as US Hedge Fund Pushes for Formal Sale XCF Global SAFX Q1 2026 Earnings EPS 005 Beats Estimates Nvidia Options Activity Signals Caution Ahead of Earnings Vodafone VOD Gained 067 Can It Break 1586 20260519 Spartacus TMTSU Stalls at 1026 Consolidation Phase 20260515 Amazon Prime Video Debuts SpiderNoir Series Starring Nicolas Cage Intuit Faces Mixed Analyst Perspectives Amid Market Dynamics Plus500 Reports 11 Revenue Growth Reaffirms FullYear Guidance Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Gas Prices Hit 455 National Average Consumer Strategies to Mitigate Fuel Costs Londons Tipping Point East Salvage Scheme Highlights Construction Material Reuse Potential ESI Q1 2026 Earnings EPS Beats Estimates Shares Gain IMA Q1 2026 Earnings Missed EPS Estimates Amid Continued Pipeline Development Spectral AI Inc MDAI Q1 2026 Earnings WiderThanExpected Loss Amid Absent Revenue Disclosure LUXE Q1 2026 Earnings EPS Misses Estimates by 225 Stock Declines MCK Q1 2026 Earnings Slight EPS Beat Amid Steady Performance Neurocrine Biosciences NBIX Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher Terns Pharmaceuticals Holds Steady Near Support as Biotech Sentiment Remains Mixed CalciMedica CALC Holds Near Support as Price Movement Remains Minimal Zhibao Technology ZBAO Holds Near Support as Modest Gains Test Resistance Levels Accendra Health ACH Edges Higher Key Levels to Watch After 277 Gain First Busey Preferred Stock BUSEP Holds Steady Near Resistance Modest Uptrend Underway